Travere Therapeutics (TVTX) Return on Equity [ROE] (2014 - 2026)
Travere Therapeutics' Return on Equity [ROE] was -515.89% in Q3 2026, down 349.32 percentage points from -166.57% a year earlier and down 445.36 percentage points from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Travere Therapeutics came in at -29.38%, up 218.07 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of +48.99 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -247.45% in FY2024 (-156.01 pp), -91.44% in FY2023 (+70.02 pp), -161.46% in FY2022 (-91.29 pp) and -70.17% in FY2021 (+8.20 pp).
- The Q3 2026 figure marks the lowest quarterly Return on Equity [ROE] since Q4 2024.
- Compared with a year earlier, Return on Equity [ROE] was higher in three of the last seven quarters, with an average year-over-year change of +3.38 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q4 2025 (a gain of 2219.93 percentage points); the worst was Q4 2024 (a drop of 2200.69 percentage points).
- Per Business Quant data, TVTX's Return on Equity [ROE] in the three quarters before Q3 2026 was -70.53% (Q2 2026), -20.06% (Q1 2026) and -27.12% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Travere Therapeutics | 4.97 Bn | 4.56 Bn | 221.70 Mn | -520.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -520.10% |
| Jun 30, 2026 | -71.02% |
| Mar 31, 2026 | -20.27% |
| Dec 31, 2025 | -28.30% |
| Sep 30, 2025 | -166.64% |
| Jun 30, 2025 | -513.14% |
| Mar 31, 2025 | -491.10% |
| Dec 31, 2024 | -2,237.14% |
| Jun 30, 2024 | -322.10% |
| Mar 31, 2024 | -117.03% |
| Dec 31, 2023 | -45.76% |
| Sep 30, 2023 | -45.93% |
| Jun 30, 2023 | -203.00% |
| Mar 31, 2023 | -249.43% |
| Dec 31, 2022 | -391.32% |
| Sep 30, 2022 | -204.67% |
| Jun 30, 2022 | -126.44% |
| Mar 31, 2022 | -79.81% |
| Dec 31, 2021 | -58.98% |
| Sep 30, 2021 | -78.48% |
API Access
Travere Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();